Salk Institute Study Finds Methionine Supplementation Protects Mice from Fatal Inflammation
Similar Articles
Researchers Identify Chemical Trigger for Brain Inflammation in Alzheimer's Disease
Study Finds Stabilizing Key Protein Reduces Frailty in Aging Mice
Study Identifies Cysteine as a Key Nutrient for Intestinal Repair
Brain Protein Decline Linked to Aging, With Reversal Possible in Mice
Research Identifies Protein Target That Improves Memory in Alzheimer's Mouse Model
Researchers at the Salk Institute have discovered that supplementing the diet with the essential amino acid methionine protected mice from fatal inflammation during infection. The treatment allowed the mice to continue fighting the pathogen while the methionine helped their kidneys filter and remove harmful inflammatory cytokines from the blood. The findings, published in Cell Metabolism, suggest a new approach to managing severe inflammatory conditions like sepsis.
Facts First
- Methionine supplementation protected infected mice from wasting, blood-brain barrier problems, and death.
- The treatment lowered harmful cytokine levels by increasing kidney filtration and cytokine removal through urine.
- Methionine did not interfere with the immune response, allowing mice to continue fighting the pathogen.
- The findings were also protective in models of sepsis and kidney injury.
- The research was supported by multiple grants from the National Institutes of Health, the Howard Hughes Medical Institute, and private foundations.
What Happened
Scientists at the Salk Institute studied mice infected with the pathogen Yersinia pseudotuberculosis to observe systemic inflammation. The infected mice ate less and had low levels of the essential amino acid methionine in their blood. When researchers supplemented the diet of a group of infected mice with methionine, it protected them from wasting, blood-brain barrier problems, and death linked to inflammation. The methionine allowed the mice to continue fighting and killing the pathogen by lowering cytokine levels in the blood. In separate models of sepsis and kidney injury, methionine also provided protection to the mice.
Why this Matters to You
Severe inflammation is a major driver of death in serious infections and conditions like sepsis. This research in mice points to a potential future treatment pathway that could help the body manage its own inflammatory response without compromising its ability to fight an infection. If similar effects are found in humans, it could lead to new supportive therapies for critically ill patients, potentially improving survival rates from severe inflammatory diseases.
What's Next
The findings, published in the journal Cell Metabolism, represent early-stage animal research. The next steps will likely involve testing whether methionine supplementation has similar protective effects in human patients facing severe inflammatory conditions. This research may open new avenues for developing treatments that help the body tolerate disease while maintaining its defensive capabilities.